103 related articles for article (PubMed ID: 1545171)
21. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
[TBL] [Abstract][Full Text] [Related]
22. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
[TBL] [Abstract][Full Text] [Related]
23. [The value of marker antigens TPS, SCC and CEA in diagnosis, evaluation of histologic type and clinical disease progression in patients with cervical carcinoma].
Zakrzewska I
Pol Merkur Lekarski; 2001 Jan; 10(55):21-3. PubMed ID: 11320545
[TBL] [Abstract][Full Text] [Related]
24. [Tumor markers in uterine cancers].
Fukasawa I; Kousaka N; Kun Z; Inaba N
Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of carcinoembryonic antigen, tissue polypeptide antigen, and squamous cell carcinoma antigen in the detection of cervical cancers.
Lam CP; Yuan CC; Jeng FS; Tsai LC; Yeh SH; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):7-13. PubMed ID: 1326391
[TBL] [Abstract][Full Text] [Related]
26. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
27. Clinical evaluation of serum and immunohistochemical expression of SCC and CA19-9 in radiation therapy for cervical cancer.
Abe A; Nakano T; Morita S; Oka K
Anticancer Res; 1999; 19(1B):829-36. PubMed ID: 10216501
[TBL] [Abstract][Full Text] [Related]
28. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
[TBL] [Abstract][Full Text] [Related]
29. Tumor marker concentrations in normal and malignant tissues of colorectal cancer patients and their prognostic relevance.
Gebauer G; Müller-Ruchholtz W
Anticancer Res; 1997; 17(4A):2731-4. PubMed ID: 9252706
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of serum levels of SCC antigen in patients with esophageal squamous cell carcinoma].
Ikeda K; Terashima M; Ishida K; Okamoto K; Suzuki S; Murakami K; Ohtsu T; Suzuki K; Niitsu Y; Obonai H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):677-82. PubMed ID: 3355186
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the prognostic significance of cytosolic determination of CA 125 tumor-associated antigen, carcinoembryonic antigen and squamous cell carcinoma antigen in patients with nonsmall cell lung carcinoma.
Picardo AL; Diez M; Torres A; Maestro M; Ortega D; Hernando F; Gómez A; Garcia-Asenjo J; Balibrea JL
Cancer; 1996 Mar; 77(6):1066-72. PubMed ID: 8635125
[TBL] [Abstract][Full Text] [Related]
32. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses.
Carter PG; Iles RK; Neven P; Davies AP; Shepherd JH; Chard T
Gynecol Oncol; 1993 Dec; 51(3):368-71. PubMed ID: 8112647
[TBL] [Abstract][Full Text] [Related]
33. [Diagnostic significance of tumor markers for gynecologic malignancies].
Aoki D; Hirasawa A; Susumu N
Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
[TBL] [Abstract][Full Text] [Related]
34. Enzyme Immunoassay of Urinary β-Core Fragment of Human Chorionic Gonadotropin as a Tumor Marker for Ovarian Cancer.
Nishimura R; Koizumi T; Das H; Takemori M; Hasegawa K
Methods Mol Med; 2001; 39():135-41. PubMed ID: 21340764
[TBL] [Abstract][Full Text] [Related]
35. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
36. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
Kinugasa M; Nishimura R; Koizumi T; Morisue K; Higashida T; Natazuka T; Nakagawa T; Isobe T; Baba S; Hasegawa K
Jpn J Cancer Res; 1995 Aug; 86(8):783-9. PubMed ID: 7559103
[TBL] [Abstract][Full Text] [Related]
37. Assessment of serum CYFRA 21-1 in lung cancer.
Muraki M; Tohda Y; Iwanaga T; Uejima H; Nagasaka Y; Nakajima S
Cancer; 1996 Apr; 77(7):1274-7. PubMed ID: 8608502
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C
Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853
[TBL] [Abstract][Full Text] [Related]
39. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
[TBL] [Abstract][Full Text] [Related]
40. [A clinical study on multiple tumor markers following therapy in patients with uterine cervical carcinoma].
Hiura M; Yorishima M; Tanaka M; Yokoyama T; Myoga H; Chiba T; Nakanishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1990 May; 42(5):471-8. PubMed ID: 2373919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
